Skip to main content

Table 2 Clinical presentation and follow-up of 83 university students with acute pharyngitis

From: Throat and nasal swabs for molecular detection of respiratory viruses in acute pharyngitis

  Virus only Streptococcal ± virusc  
E/Ra Flu Corona-virusa Otherb Negatives
No. patients at presentationa 19 8 9 5 20 23
Symptom duration, median no. of days (IQR) 3 (1) 3 (0) 3 (1) 3 (0) 2 (2) 2 (1)
Symptoms, n (%)       
 Sore throatd 19 (100) 8 (100) 9 (100) 5 (100) 20 (100) 23 (100)
 Cough 16 (84) 8 (100) 7 (78) 4 (80) 13 (65) 15 (65)
 Fever 12 (63) 8 (100) 3 (33) 5 (100) 18 (90) 9 (39)
 Sneezing 14 (74) 6 (75) 7 (78) 4 (80) 7 (35) 7 (30)
 Runny nose 18 (95) 8 (100) 7 (78) 4 (80) 13 (65) 12 (52)
 Headache 13 (68) 7 (88) 5 (56) 5 (100) 14 (70) 13 (57)
 Sinus pain/pressure 12 (63) 7 (88) 5 (56) 3 (60) 10 (50) 8 (35)
 Cervical lymphadenopathy 10 (53) 6 (75) 3 (33) 3 (60) 15 (75) 13 (57)
No. (%) prescribed antibiotic 3 (16) 0 (0) 1 (11) 1 (20) 15 (75) 8 (35)
No. patients at one-week follow-up 19 7 9 6 19 21
Symptom duration, median no. of days (IQR) 4 (4) 4 (2) 7 (3) 4 (2) 3 (3) 7 (3)
No. (%) who missed ≥ 1 day of school 5 (26) 5 (71) 4 (44) 3 (50) 13 (68) 6 (29)
  1. Abbreviations: E/R Enterovirus/rhinovirus, IQR Interquartile range
  2. aOne patient with co-infection of rhinovirus and coronavirus HKU1 was analyzed in both columns
  3. bIncludes patients with adenovirus (n = 1), metapneumovirus (n = 2) and respiratory syncytial virus (n = 2)
  4. cIncludes patients with group A (n = 17) and group C (n = 3) beta-hemolytic streptococci, with five and three viral co-infections, respectively. No group G beta-hemolytic streptococci were detected
  5. dBy definition, this proportion is 100 % given study inclusion criteria